Our research in medical imaging

MMI remains on the cutting-edge of medical imaging by actively participating in industry-led and academic research.

We provide services and support for over 150 industry-led clinical trials and conduct pure academic studies from universities across the greater Sydney basin.

We also conduct our own research internally to raise new standards in image quality and translate research techniques into standard clinical practice.

MMI is uniquely placed to conduct translational research in a variety of fields including:

  • oncology
  • dementias (Alzheimer’s, Vascular, Frontoparietal, mild cognitive impairment)
  • Parkinson’s disease
  • movement disorders
  • respiratory and cardiovascular diseases.

Strong industry relationships with GE and Siemens provides access and support for emerging technologies.

MMI, as part of MQ University  is a proud partner of the National Imaging Facility (NIF)

Clinical trials services

MMI has extensive medical imaging experience with industry-led pharmaceutical clinical trials. Conducting imaging for over 70 clinical trials, MMI is accredited with multiple central readers. Quality assurance is regulated by our standard operating procedures.

We offer whole-body imaging across all modalities (CT, MRI, PET, Nuclear Medicine, Ultrasound, X-Ray) backed by state-of-the-art technology built to meet Good Clinical Practice (GCP) standards.

Our strong working relationship with PET radiopharmaceutical manufacturer Cyclotek Pty Ltd enables access to an expanding list of PET radiopharmaceuticals. These qualities have resulted in MMI’s selection as the only site in the Southern Hemisphere to participate in the prestigious PPMI study.

MMI understands the clinical landscape and appreciates crucial trial timelines, which drives our scheduling flexibility. Our dedicated research team is led by a Postdoctoral Research Fellow with extensive knowledge of good research practices. We strive to lead the way in medical imaging.